Can one study change clinical practice?
Professor Doug McKell explains why ORBITA might not be enough to reduce unnecessary stents. More
HPV protection or cancer vaccine? Putting Gardasil in context
Why was Gardasil originally marketed as a cervical cancer vaccine? Professor Samantha Gottlieb explains. More
INTERVIEW: Dr. David Brown on startling stent study
Cardiologist David Brown addresses some of the criticisms of the controversial ORBITA trial. More
Value-based care initiatives floundering in a broken system
Does value-based care stand a chance against the fee-for-service Goliath? More
Lown president, cardiologist, reacts to stent controversy
A study in The Lancet this week has rocked the world of cardiology by showing that stents are no better than a placebo in relieving chest pain. More
Health care? More like health scare!
Every day is Halloween for pharma marketers... More
Navigating the mess of medical misinformation
Why is clinical research such a mess? And how can we clean it up? More
Is there a middle ground in the statin debate?
How do we balance evidence and patient preferences in the intensifying statin debate? More
Why is pediatric overuse being overlooked?
Medical overuse is just as much a problem in children's health care as it is for adults, so why isn't there more recognition of this issue? More
Maryland’s all-payer system shows hospitals can live within their means
Fee-for-service drives overuse and high costs, but what's the alternative? Maryland may have the answer. More
When quality performance measures don’t pass the test
Rewarding doctors for following quality measures should be a win-win, but there's one problem- many of these measures don't actually make patients healthier. More
Right Care Vignette winner sounds the alarm on unnecessary bed alarms
What do you do when your patient’s well-being is threatened by rules beyond your control? More
Right Care Series in The Lancet
With the Right Care Series, published by The Lancet in 2017, the Lown Institute launched a global effort to assess the scope of overuse and underuse and place these twin failings at the center of health strategies everywhere to achieve the right care for all people. The Institute organized a team of 27 international experts from nine countries and 21 institutions. More
A patient’s story: After research, a push back on thyroid surgery
When Julie Martinez was diagnosed with thyroid cancer, she started doing research on overdiagnosis, and was shocked by what she found... More